The
anti-obesity drug market has seen rising prominence over the years owing to the
growing prevalence of obesity across both developed and developing countries.
Anti-obesity drugs help reduce body weight and manage obesity by decreasing
appetite, blocking the absorption of fat, or increasing feelings of fullness.
Some commonly prescribed anti-obesity medications include Orlistat,
Phentermine, and Liraglutide. Orlistat works by preventing the absorption of
around 30% of fat from the consumed food. Phentermine is a stimulant that
suppresses appetite. Liraglutide which is also used for diabetes management induces
a feeling of fullness.
The global anti-obesity drug market is estimated to be valued at US$ 2,542.0 million in 2023 and is expected to
exhibit a CAGR of 16.1% during the forecast period (2023-2030).
Key Takeaways
Key players operating in the anti-obesity drug market are ARJO, Etac AB,
Medline Industries Inc., Guldmann Inc., Sunrise Medical Inc., Stryker
Corporation, Winncare Group (Mangar Health), Joerns Healthcare Inc., Invacare
Corporation, Baxter (Hill Rom Holding Inc.), Gainsborough Healthcare Group, and
Savaria Corporation (Handicare Group AB), among others.
The growing prevalence of obesity caused by sedentary lifestyles and unhealthy
eating habits has increased the demand for anti-obesity drugs in recent years.
Pharmaceutical companies are focusing on developing more effective and safer
drugs to treat obesity and related comorbidities.
Many anti-obesity drug manufacturers are also looking at expanding their
presence globally, especially in emerging economies where obesity rates are
rising rapidly due to changing consumption patterns and urbanization.
Partnerships with local distributors help ensure steady revenue streams from
international markets.
Market Key Trends
Combination therapies have emerged as a key trend in the Anti-Obesity
Drug Market Demand. Using medications that target different mechanisms
simultaneously maximizes weight loss effects. Studies have shown anti-obesity
drugs coupled with lifestyle therapies lead to better long-term outcomes. Many
pharmaceutical firms are conducting clinical trials of fixed-dose combinations
which they hope will address both effectiveness and safety issues of
monotherapies. This represents a significant opportunity for anti-obesity drug
makers going forward.
Porter’s
Analysis
Threat of new entrants: High capital requirements to enter industry reduce
threat. Bargaining power of buyers: Buyers have less bargaining power due to
availability of fewer substitutes. Bargaining power of suppliers: Suppliers
have more bargaining power as switching costs are high for changing suppliers.
Threat of new substitutes: Threat of new substitutes is moderate as obesity
treatment options increase. Competitive rivalry: Intense rivalry exists due to
presence of big and small players.
North America holds the largest share of the anti-obesity drugs market due to
growing obese population and high awareness levels. The United States accounts
for the major share in the North American as well as global anti-obesity drugs
market. However, Asia Pacific region is expected to witness the highest growth
over the forecast period owing increasing obese population especially in India
and China along with growing healthcare expenditure in the region.
Geographical Regions
Geographical analysis shows that North America accounts for the major market
share in terms of value with the United States being the major contributor.
Growing obese population coupled with increasing awareness levels regarding
obesity management in the region drive substantial market demand.
The Asia Pacific region is poised to witness fastest growth over the forecast
period owing to increasing obese population especially in India and China as a
result of changing lifestyle patterns and consumption of junk food.
Additionally, rising healthcare expenditure in Asia Pacific countries will
further aid market expansion in the coming years.
Get more insights on – Anti-Obesity
Drugs Market
Get More Insights—Access the Report in the Language
that Resonates with You.
About Author:
Ravina Pandya, Content Writer, has a strong foothold
in the market research industry. She specializes in writing well-researched
articles from different industries, including food and beverages, information
and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
